http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021186699-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f3310ecee5cf73a0cca645ea199534a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0464
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2466
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24
filingDate 2021-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67482197fa9f2d18cc9a238568438cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f3f7f394fdb8bf505bac20058c82b59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f109f40581f3a7078f5da9ef2cad6676
publicationDate 2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021186699-A1
titleOfInvention Method and apparatus for transvascular implantation of neo chordae tendinae
abstract Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684475-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666441-B2
priorityDate 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408540

Total number of triples: 37.